Zanidatamab,Tislelizumab,Trastuzumab
jazz pharma,zymeworks,roche
[]
jazz &amp; announce preliminary phase 2 trial data presented today at #ascogi on a her2-targeted bispecific antibody in metastatic gastroesophageal #adenocarcinoma (#mgea).
We’re a global biopharma company developing life-changing medicines for people with limited or no options. Please see our social guidelines - https://t.co/ny1WC5R7Gb